The Chemistry Resource Laboratory is an integral part of Roswell Park's drug development program. This resource provides chemistry services (professional advice, technical assistance, chemical syntheses) to the Institute staff members in support of their efforts to develop new anti- cancer therapies and compounds for use in studies related to mode(s) of action of cancer drug(s), biotransformation, drug disposition, etc. The """"""""added value"""""""" of this resource is the unique expertise and state-of-the-art equipment that it provides to deal with all aspects of medicinal chemistry, including the synthesis of a wide and diverse array of compounds such as anti-folates, nucleotides/nucleotide, membrane-active carbohydrates, amino acid analogues, polyamines, anti-sense agents (oligomer-dye complex) porphyrins, modified monomers for modified biopolymer syntheses and reference metabolites. The functions of this CCSG shared resource are: 1) to synthesize potential anti-cancer agents, e.g., in 5-200 g quantities for extensive preclinical chemotherapy; toxicological and pharmacological studies; 2) to prepare key intermediates in 20 g-Kg quantities for the synthesis of potential anti-cancer agents by research chemists at RPCI; 3) to prepare radioactive compounds (3H and 14C labeled) for mechanism of action and drug disposition studies: 4) to synthesize reference metabolites of active compounds for characterization purposes; and 5) to synthesize individual special compounds that demonstrate interesting and/or novel biological activities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-26
Application #
6452244
Study Section
Project Start
2001-05-07
Project End
2003-04-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Soh, Kah Teong; Wallace, Paul K (2018) RNA Flow Cytometry Using the Branched DNA Technique. Methods Mol Biol 1678:49-77
Ramakrishnan, Swathi; Huss, Wendy; Foster, Barbara et al. (2018) Transcriptional changes associated with in vivo growth of muscle-invasive bladder cancer cell lines in nude mice. Am J Clin Exp Urol 6:138-148
Chang, Han-Wen; Valieva, Maria E; Safina, Alfiya et al. (2018) Mechanism of FACT removal from transcribed genes by anticancer drugs curaxins. Sci Adv 4:eaav2131
Dong, Jing; Buas, Matthew F; Gharahkhani, Puya et al. (2018) Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology 154:1273-1281.e3
Drakhshandeh, Dori; Miller, James A; Fabiano, Andrew J (2018) Instrumented Spinal Stabilization without Fusion for Spinal Metastatic Disease. World Neurosurg 111:e403-e409
Gong, Zhihong; Wang, Jie; Wang, Dan et al. (2018) Differences in microRNA expression in breast cancer between women of African and European ancestry. Carcinogenesis :
Mahoney, Martin C; Erwin, Deborah O; Twarozek, Annamaria Masucci et al. (2018) Leveraging technology to promote smoking cessation in urban and rural primary care medical offices. Prev Med 114:102-106
Cheng, Ting-Yuan David; Darke, Amy K; Redman, Mary W et al. (2018) Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424). J Natl Cancer Inst 110:734-742
Zonneville, Justin; Safina, Alfiya; Truskinovsky, Alexander M et al. (2018) TGF-? signaling promotes tumor vasculature by enhancing the pericyte-endothelium association. BMC Cancer 18:670
Haring, Rodney C; Henry, Whitney Ann; Hudson, Maui et al. (2018) Views on clinical trial recruitment, biospecimen collection, and cancer research: population science from landscapes of the Haudenosaunee (People of the Longhouse). J Cancer Educ 33:44-51

Showing the most recent 10 out of 1555 publications